Wadjing, Bb Girl .

HRN: 21-57-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2022
AMPICILLIN 250MG (VIAL)
08/27/2022
09/03/2022
IV
165 Mg
Q12
MSAF Thicly
Waiting Final Action 
08/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/27/2022
09/03/2022
IV
49 Mg
Q24
MSAF Thickly
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: